As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Dry Eye Syndrome Market: By Disease Type; By Drug Type; By Product; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2015-2025); Market Dynamics; Value Chain Analysis; Manufacturing Process; Competitive Landscape; Industry Events and Developments

Global Dry Eye Syndrome Market Outlook

The global dry eye syndrome market size was worth USD 3.5 billion in 2019. The market is further expected to grow at a CAGR of 6.8% between 2020 and 2025 to reach a value of approximately USD 5.2 billion by 2025. 

The R&D partnership and the Choice and Lice agreement for the development of gene therapy vectors for retinal diseases were concluded in June 2019 with Santen Pharmaceutical Co., Ltd. and Oxford Biomedica. This R&D partnership primarily aims to produce pre-clinical evidence for OXB's idea for the treatment of inherited retinal diseases using lentiviral vectors. This will support the company's product growth, which will also aid the growth of the overall market.

 

Properties and Applications

Dry eye syndrome, scientifically identified as keratoconjunctivitis sicca (KCS), refers to a distinguishing concept of the person's eye surface that lacks lubrication or moisture. It is a severe disease that can affect virtually everyone. Several dry eye signs include nausea and burning sensations, eyes swollen, red eyes, fatigued eyes, itchy eyes, and photophobia, among others. In addition, watery eyes may also be a symptom, as a dry eye surface over-stimulates the development of watery tears to alleviate the dryness. Dry eye disease can be caused by excessive use of computers, allergies, obesity, menopause, smoking, LASIK eye surgery, and hormone replacement therapy, among others.

Based on disease type, the market is divided into the following:

  • Evaporative 
  • Aqueous 

Based on drug type, the market can be divided into the following:

  • Anti-Inflammatory Drugs
  • Lubricant Eye Drops
  • Autologous Serum Eye Drops 

On the basis of product, the industry can be segmented into:

  • Liquid Drops 
  • Gel 
  • Liquid Wipes 
  • Eye Ointment 
  • Others

Based on distribution channel, the market can be divided into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies 

The regional markets for the product include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

 

Market Analysis

The development of the global dry eye syndrome market is largely due to the rise in the widespread occurrence of dry eye syndrome, which is attributed to a variety of factors. The increasing geriatric population around the world has resulted in a rise in the incidence of the syndrome because tear glands weaken because of their ageing and cannot produce enough tear fluid to hold a lubricating film on the eyes. Another key factor for the rising incidence of dry eye syndrome is the higher prevalence of other conditions, which can affect the functioning of the eye like diabetes. The changes in patient's blood composition due to diabetes will adversely affect the weeping glands, causing dry eye syndrome. Many diseases that can cause dry-eye syndrome indirectly include vitamin A deficiency, lupus, thyroid disease, and rheumatoid arthritis. The growing occurrence of such diseases in the market is expected to aid the overall market growth.

 

Competitive Landscape 

The report gives a detailed analysis of the following key players in the global dry eye syndrome market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Akorn, Incorporated.
  • Allergan 
  • Auven Therapeutics
  • Nicox S.A.
  • Novartis AG 
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Dry Eye Syndrome Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Dry Eye Syndrome Historical Market (2015-2019) 
    8.3    Global Dry Eye Syndrome Market Forecast (2020-2025)
    8.4    Global Dry Eye Syndrome Market by Disease Type
        8.4.1    Evaporative Dry Eye Syndrome
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2015-2019)
            8.4.1.3    Forecast Trend (2020-2025)
        8.4.2    Aqueous Dry Eye Syndrome
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2015-2019)
            8.4.2.3    Forecast Trend (2020-2025)
    8.5    Global Dry Eye Syndrome Market by Drug Type
        8.5.1    Anti-Inflammatory Drugs
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2015-2019)
            8.5.1.3    Forecast Trend (2020-2025)
        8.5.2    Lubricant Eye Drops
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2015-2019)
            8.5.2.3    Forecast Trend (2020-2025)
        8.5.3    Autologous Serum Eye Drops
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2015-2019)
            8.5.3.3    Forecast Trend (2020-2025)
8.6    Global Dry Eye Syndrome Market by Product
    8.6.1    Liquid Drops
        8.6.1.1    Market Share
        8.6.1.2    Historical Trend (2015-2019)
        8.6.1.3    Forecast Trend (2020-2025)
    8.6.2    Gel
        8.6.2.1    Market Share
        8.6.2.2    Historical Trend (2015-2019)
        8.6.2.3    Forecast Trend (2020-2025)
    8.6.3    Liquid Wipes
        8.6.3.1    Market Share
        8.6.3.2    Historical Trend (2015-2019)
        8.6.3.3    Forecast Trend (2020-2025)
    8.6.4    Eye Ointment
        8.6.4.1    Market Share
        8.6.4.2    Historical Trend (2015-2019)
        8.6.4.3    Forecast Trend (2020-2025)
    8.6.5    Others
8.7    Global Dry Eye Syndrome Market by Distribution Channel
    8.7.1    Hospital Pharmacies
        8.7.1.1    Market Share
        8.7.1.2    Historical Trend (2015-2019)
        8.7.1.3    Forecast Trend (2020-2025)
    8.7.2    Retail Pharmacies
        8.7.2.1    Market Share
        8.7.2.2    Historical Trend (2015-2019)
        8.7.2.3    Forecast Trend (2020-2025)
    8.7.3    Online Pharmacies
        8.7.3.1    Market Share
        8.7.3.2    Historical Trend (2015-2019)
        8.7.3.3    Forecast Trend (2020-2025)
8.8    Global Dry Eye Syndrome Market by Region
    8.8.1    Market Share
        8.8.1.1    North America
        8.8.1.2    Europe
        8.8.1.3    Asia Pacific
        8.8.1.4    Latin America
        8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2015-2019)
        9.1.2    Forecast Trend (2020-2025)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2015-2019)
        9.2.2    Forecast Trend (2020-2025)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2015-2019)
        9.3.2    Forecast Trend (2020-2025)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2015-2019)
        9.4.2    Forecast Trend (2020-2025)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2015-2019)
        9.5.2    Forecast Trend (2020-2025)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyers Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Manufacturing Process

    12.1    Detailed Process Flow
    12.2    Operations Involved
    12.3    Mass Balance
13    Competitive Landscape
    13.1    Market Structure
    13.2    Key Players’ Market Share
    13.3    Company Profiles
        13.3.1    Akorn, Incorporated.
            13.3.1.1    Company Overview
            13.3.1.2    Company Description
        13.3.2    Allergan
            13.3.2.1    Company Overview
            13.3.2.2    Company Description
        13.3.3    Auven Therapeutics
            13.3.3.1    Company Overview
            13.3.3.2    Company Description
        13.3.4    Nicox S.A.
            13.3.4.1    Company Overview
            13.3.4.2    Company Description
        13.3.5    Novartis AG
            13.3.5.1    Company Overview
            13.3.5.2    Company Description
        13.3.6    Others
14    Industry Events and Developments

 

List of Figures and Tables

1.    Global Dry Eye Syndrome Market: Key Industry Highlights, 2015 and 2025
2.    Global Dry Eye Syndrome Historical Market: Breakup by Disease Type (USD Billion), 2015-2019
3.    Global Dry Eye Syndrome Market Forecast: Breakup by Disease Type (USD Billion), 2020-2025
4.    Global Dry Eye Syndrome Historical Market: Breakup by Drug Type (USD Billion), 2015-2019
5.    Global Dry Eye Syndrome Market Forecast: Breakup by Drug Type (USD Billion), 2020-2025
6.    Global Dry Eye Syndrome Historical Market: Breakup by Product (USD Billion), 2015-2019
7.    Global Dry Eye Syndrome Market Forecast: Breakup by Product (USD Billion), 2020-2025
8.    Global Dry Eye Syndrome Historical Market: Breakup by Distribution Channel (USD Billion), 2015-2019
9.    Global Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (USD Billion), 2020-2025
10.    Global Dry Eye Syndrome Historical Market: Breakup by Region (USD Billion), 2015-2019
11.    Global Dry Eye Syndrome Market Forecast: Breakup by Region (USD Billion), 2020-2025
12.    North America Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
13.    North America Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
14.    Europe Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
15.    Europe Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
16.    Asia Pacific Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
17.    Asia Pacific Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
18.    Latin America Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
19.    Latin America Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
20.    Middle East and Africa Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2015-2019
21.    Middle East and Africa Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2020-2025
22.    Global Dry Eye Syndrome Market Structure

Key Questions Answered in the Report

In 2019, the global dry eye syndrome market attained a value of nearly USD 3.5 billion.

The market is projected to grow at a CAGR of 6.8% between 2020 and 2025.

The market is estimated to witness a healthy growth in the forecast period of 2020-2025 to reach about USD 5.2 billion by 2025.

The major drivers of the industry, such as the rising occurrence of dry eye syndrome, increasing geriatric population, and changing lifestyles, are expected to aid the market growth.

The key trend guiding the growth of the market includes the rising R&D activities in the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific. 

Evaporative and aqueous dry eye syndromes are the major disease types in the industry.

Anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops are the major drug types in the industry.

Liquid drops, gel, liquid wipes, and eye ointment, among others, are the major products in the industry.

The major distribution channels in the industry are hospital pharmacies, retail pharmacies, and online pharmacies.

The major players in the industry are Akorn, Incorporated., Allergan, Auven Therapeutics, Nicox S.A., and Novartis AG, among others.

Analyst Review

The global dry eye syndrome market attained a value of USD 3.5 billion in 2019, driven by the rising geriatric population. Aided by the technological innovations, the market is expected to witness a further growth in the forecast period of 2020-2025, growing at a CAGR of 6.8%. The market is projected to reach USD 5.2 billion by 2025. 

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its disease types, the industry can be segmented into evaporative and aqueous dry eye syndromes. On the basis of drug types, the industry is categorised into anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops. On the basis of products, the industry is divided into liquid drops, gel, liquid wipes, eye ointment, and others. On the basis of distribution channels, the industry is categorised into hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for the product are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Akorn, Incorporated., Allergan, Auven Therapeutics, Nicox S.A., Novartis AG, and others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1099
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Single User License

$2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • Free Update in 180 Days

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

China Diabetes Market Report and Forecast 2020-2025


Indian Diabetes Market Report and Forecast 2020-2025


Canada Diabetes Market Report and Forecast 2020-2025




NEWSLETTER